SEC Tracker
Get the app

Integer Holdings ITGR

Integer Holdings Q1 FY25: revenue $437.4M, up 5%; diluted EPS −$0.66

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Integer Holdings reported for Q1 FY25, the quarter ended Mar 28, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$437.4M+5% from $414.8M in Q1 FY2410-Q income statement, on EDGAR
  2. Net income−$22.5M−210% from $20.5M in Q1 FY2410-Q income statement, on EDGAR
  3. Diluted EPS−$0.66−212% from $0.59 in Q1 FY2410-Q income statement, on EDGAR
  4. Cash and cash equivalents$31.7M−25% from $42.2M in Q1 FY2410-Q balance sheet, on EDGAR
  5. Cash from operations$31.3M+35% from $23.2M in Q1 FY2410-Q cash flow statement, on EDGAR

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Integer Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3845 and related industry codes: the same peer list as the financial tables.

  1. TransMedics Group TMDX public float $4.4B, Jun 30, 2025
  2. Masimo MASI public float $3.9B, Jun 28, 2025
  3. Inspire Medical Systems INSP public float $3.8B, Jun 30, 2025
  4. iRhythm Holdings IRTC public float $4.9B, Jun 30, 2025
  5. Merit Medical Systems MMSI public float $5.4B, Jun 30, 2025